KIDNEY TRANSPLANT RECIPIENT
Clinical trials for KIDNEY TRANSPLANT RECIPIENT explained in plain language.
Never miss a new study
Get alerted when new KIDNEY TRANSPLANT RECIPIENT trials appear
Sign up with your email to follow new studies for KIDNEY TRANSPLANT RECIPIENT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Washing kidneys to stop hidden virus: new trial aims to make transplants safer
Disease control Not yet recruitingThis early-stage trial tests whether treating a donor kidney with a drug called SYN002 before transplant can safely reduce the risk of passing cytomegalovirus (CMV) to the recipient. About 12 adults waiting for a kidney transplant will receive a treated organ. The main goal is to…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Phase: EARLY_PHASE1 • Sponsor: University Health Network, Toronto • Aim: Disease control
Last updated Jun 27, 2026 12:00 UTC
-
Could a common diabetes drug stop diabetes after kidney transplant?
Prevention Not yet recruitingThis trial tests whether taking dapagliflozin (Forxiga) for 12 months can prevent post-transplant diabetes in kidney transplant recipients who do not have diabetes. The study includes 184 adults who recently received a kidney transplant and are on standard immunosuppressive thera…
Matched conditions: KIDNEY TRANSPLANT RECIPIENT
Phase: PHASE2 • Sponsor: Odense University Hospital • Aim: Prevention
Last updated Jul 03, 2026 20:42 UTC